<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>propantheline</title><link>http://www.unboundmedicine.com/medline/ebm/research/propantheline</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Response to "suspected differential interactions of digoxin with imidafenacin and propantheline; some thoughts for introspection".</title><link>http://www.unboundmedicine.com/medline/ebm/record/19881263/full_citation/Response_to_"suspected_differential_interactions_of_digoxin_with_imidafenacin_and_propantheline;_some_thoughts_for_introspection"_</link><description>Nakade S, Ohno T, Ogawa M <br/><span class="title">Response to "suspected differential interactions of digoxin with imidafenacin and propantheline; some thoughts for introspection". [Journal Article]</span><br/><span class="source" title="Drug metabolism and pharmacokinetics">Drug Metab Pharmacokinet 2009; 24(5):486-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19881263/full_citation/Response_to_&#34;suspected_differential_interactions_of_digoxin_with_imidafenacin_and_propantheline;_some_thoughts_for_introspection&#34;_">Full Citation</a></description></item><item><title>Desirable pharmacokinetic properties of (13)C-uracil as a breath test probe of gastric emptying in comparison with (13)C-acetate and (13)C-octanoate in rats.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19585373/full_citation/Desirable_pharmacokinetic_properties_of__13_C_uracil_as_a_breath_test_probe_of_gastric_emptying_in_comparison_with__13_C_acetate_and__13_C_octanoate_in_rats_</link><description>Sugiyama E, Inada M, Kunizaki JI, et al. <br/><span class="title">Desirable pharmacokinetic properties of (13)C-uracil as a breath test probe of gastric emptying in comparison with (13)C-acetate and (13)C-octanoate in rats. [JOURNAL ARTICLE]</span><br/><span class="source" title="Scandinavian journal of gastroenterology">Scand J Gastroenterol 2009 Jul 7.:1-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19585373/abstract/Desirable_pharmacokinetic_properties_of__13_C_uracil_as_a_breath_test_probe_of_gastric_emptying_in_comparison_with__13_C_acetate_and__13_C_octanoate_in_rats_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19585373/full_citation/Desirable_pharmacokinetic_properties_of__13_C_uracil_as_a_breath_test_probe_of_gastric_emptying_in_comparison_with__13_C_acetate_and__13_C_octanoate_in_rats_">Full Citation</a> | <a href="http://www.informaworld.com/openurl%3fgenre=article%26amp;doi=10.1080/00365520903114904%26amp;magic=pubmed||1B69BA326FFE69C3F0A8F227DF8201D0">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19585373/Desirable_pharmacokinetic_properties_of__13_C_uracil_as_a_breath_test_probe_of_gastric_emptying_in_comparison_with__13_C_acetate_and__13_C_octanoate_in_rats_">Find Related Articles</a> </description></item><item><title>Suspected differential interactions of digoxin with imidafenacin and propantheline; some thoughts for introspection.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19430177/full_citation/Suspected_differential_interactions_of_digoxin_with_imidafenacin_and_propantheline;_some_thoughts_for_introspection_</link><description>Srinivas NR <br/><span class="title">Suspected differential interactions of digoxin with imidafenacin and propantheline; some thoughts for introspection. [Journal Article]</span><br/><span class="source" title="Drug metabolism and pharmacokinetics">Drug Metab Pharmacokinet 2009; 24(2):194-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19430177/full_citation/Suspected_differential_interactions_of_digoxin_with_imidafenacin_and_propantheline;_some_thoughts_for_introspection_">Full Citation</a></description></item><item><title>Anticholinergics for urinary symptoms in multiple sclerosis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19160231/full_citation/Anticholinergics_for_urinary_symptoms_in_multiple_sclerosis_</link><description>Nicholas RS, Friede T, Hollis S, et al. <br/><span class="title">Anticholinergics for urinary symptoms in multiple sclerosis. [Journal Article]</span><br/><span class="source" title="Cochrane database of systematic reviews (Online)">Cochrane Database Syst Rev 2009; (1):CD004193.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19160231/abstract/Anticholinergics_for_urinary_symptoms_in_multiple_sclerosis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19160231/full_citation/Anticholinergics_for_urinary_symptoms_in_multiple_sclerosis_">Full Citation</a> | <a href="http://dx.doi.org/10.1002/14651858.CD004193.pub2">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19160231/Anticholinergics_for_urinary_symptoms_in_multiple_sclerosis_">Find Related Articles</a> </description></item><item><title>Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: Influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18715548/full_citation/Pharmacokinetics_of_meloxicam_administered_as_regular_and_fast_dissolving_formulations_to_the_rat:_Influence_of_gastrointestinal_dysfunction_on_the_relative_bioavailability_of_two_formulations_</link><description>Aghazadeh-Habashi A, Jamali F <br/><span class="title">Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: Influence of gastrointestinal dysfunction on the relative bioavailability of two formulations. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V">Eur J Pharm Biopharm 2008 Jul 31.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18715548/abstract/Pharmacokinetics_of_meloxicam_administered_as_regular_and_fast_dissolving_formulations_to_the_rat:_Influence_of_gastrointestinal_dysfunction_on_the_relative_bioavailability_of_two_formulations_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18715548/full_citation/Pharmacokinetics_of_meloxicam_administered_as_regular_and_fast_dissolving_formulations_to_the_rat:_Influence_of_gastrointestinal_dysfunction_on_the_relative_bioavailability_of_two_formulations_">Full Citation</a></description></item><item><title>Pharmacological interventions for clozapine-induced hypersalivation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18646130/full_citation/Pharmacological_interventions_for_clozapine_induced_hypersalivation_</link><description>Syed R, Au K, Cahill C, et al. <br/><span class="title">Pharmacological interventions for clozapine-induced hypersalivation. [Journal Article]</span><br/><span class="source" title="Cochrane database of systematic reviews (Online)">Cochrane Database Syst Rev 2008; (3):CD005579.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18646130/abstract/Pharmacological_interventions_for_clozapine_induced_hypersalivation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18646130/full_citation/Pharmacological_interventions_for_clozapine_induced_hypersalivation_">Full Citation</a> | <a href="http://dx.doi.org/10.1002/14651858.CD005579.pub2">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/18646130/Pharmacological_interventions_for_clozapine_induced_hypersalivation_">Find Related Articles</a> </description></item><item><title>Pharmacological Interventions for Clozapine-induced Hypersalivation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18495644/full_citation/Pharmacological_Interventions_for_Clozapine_induced_Hypersalivation_</link><description>Syed Sheriff RJ, Au K, Cahill C, et al. <br/><span class="title">Pharmacological Interventions for Clozapine-induced Hypersalivation. [JOURNAL ARTICLE]</span><br/><span class="source" title="Schizophrenia bulletin">Schizophr Bull 2008 May 20.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18495644/full_citation/Pharmacological_Interventions_for_Clozapine_induced_Hypersalivation_">Full Citation</a></description></item><item><title>No effect of imidafenacin, a novel antimuscarinic drug, on digoxin pharmacokinetics in healthy subjects.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18445988/full_citation/No_effect_of_imidafenacin_a_novel_antimuscarinic_drug_on_digoxin_pharmacokinetics_in_healthy_subjects_</link><description>Nakade S, Ohno T, Nakayama K, et al. <br/><span class="title">No effect of imidafenacin, a novel antimuscarinic drug, on digoxin pharmacokinetics in healthy subjects. [Journal Article]</span><br/><span class="source" title="Drug metabolism and pharmacokinetics">Drug Metab Pharmacokinet 2008; 23(2):95-100.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18445988/abstract/No_effect_of_imidafenacin_a_novel_antimuscarinic_drug_on_digoxin_pharmacokinetics_in_healthy_subjects_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18445988/full_citation/No_effect_of_imidafenacin_a_novel_antimuscarinic_drug_on_digoxin_pharmacokinetics_in_healthy_subjects_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/18445988/No_effect_of_imidafenacin_a_novel_antimuscarinic_drug_on_digoxin_pharmacokinetics_in_healthy_subjects_">Find Related Articles</a> </description></item><item><title>Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18439051/full_citation/Persistence_adherence_and_switch_rates_among_extended_release_and_immediate_release_overactive_bladder_medications_in_a_regional_managed_care_plan_</link><description>D'Souza AO, Smith MJ, Miller LA, et al. <br/><span class="title">Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan. [Journal Article]</span><br/><span class="source" title="Journal of managed care pharmacy : JMCP">J Manag Care Pharm 2008 Apr; 14(3):291-301.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18439051/abstract/Persistence_adherence_and_switch_rates_among_extended_release_and_immediate_release_overactive_bladder_medications_in_a_regional_managed_care_plan_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18439051/full_citation/Persistence_adherence_and_switch_rates_among_extended_release_and_immediate_release_overactive_bladder_medications_in_a_regional_managed_care_plan_">Full Citation</a></description></item><item><title>Using the Zebrafish Lateral Line to Screen for Ototoxicity.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18408970/full_citation/Using_the_Zebrafish_Lateral_Line_to_Screen_for_Ototoxicity_</link><description>Chiu LL, Cunningham LL, Raible DW, et al. <br/><span class="title">Using the Zebrafish Lateral Line to Screen for Ototoxicity. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of the Association for Research in Otolaryngology : JARO">J Assoc Res Otolaryngol 2008 Apr 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18408970/abstract/Using_the_Zebrafish_Lateral_Line_to_Screen_for_Ototoxicity_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18408970/full_citation/Using_the_Zebrafish_Lateral_Line_to_Screen_for_Ototoxicity_">Full Citation</a></description></item></channel></rss>